Abstract

Patients with Alzheimer's disease vary in their ability to sustain cognitive abilities in the presence of brain pathology. A major open question is which brain mechanisms may support higher reserve capacity, i.e. relatively high cognitive performance at a given level of Alzheimer's pathology. Higher functional MRI-assessed functional connectivity of a hub in the left frontal cortex is a core candidate brain mechanism underlying reserve as it is associated with education (i.e. a protective factor often associated with higher reserve) and attenuated cognitive impairment in prodromal Alzheimer's disease. However, no study has yet assessed whether such hub connectivity of the left frontal cortex supports reserve throughout the evolution of pathological brain changes in Alzheimer's disease, including the presymptomatic stage when cognitive decline is subtle. To address this research gap, we obtained cross-sectional resting state functional MRI in 74 participants with autosomal dominant Alzheimer's disease, 55 controls from the Dominantly Inherited Alzheimer's Network and 75 amyloid-positive elderly participants, as well as 41 amyloid-negative cognitively normal elderly subjects from the German Center of Neurodegenerative Diseases multicentre study on biomarkers in sporadic Alzheimer's disease. For each participant, global left frontal cortex connectivity was computed as the average resting state functional connectivity between the left frontal cortex (seed) and each voxel in the grey matter. As a marker of disease stage, we applied estimated years from symptom onset in autosomal dominantly inherited Alzheimer's disease and cerebrospinal fluid tau levels in sporadic Alzheimer's disease cases. In both autosomal dominant and sporadic Alzheimer's disease patients, higher levels of left frontal cortex connectivity were correlated with greater education. For autosomal dominant Alzheimer's disease, a significant left frontal cortex connectivity × estimated years of onset interaction was found, indicating slower decline of memory and global cognition at higher levels of connectivity. Similarly, in sporadic amyloid-positive elderly subjects, the effect of tau on cognition was attenuated at higher levels of left frontal cortex connectivity. Polynomial regression analysis showed that the trajectory of cognitive decline was shifted towards a later stage of Alzheimer's disease in patients with higher levels of left frontal cortex connectivity. Together, our findings suggest that higher resilience against the development of cognitive impairment throughout the early stages of Alzheimer's disease is at least partially attributable to higher left frontal cortex-hub connectivity.

Highlights

  • Biomarker studies in Alzheimer’s disease have revealed a temporal sequence of the development of brain pathologies and cognitive decline

  • To test our major hypothesis that greater gLFC-connectivity moderates the impact of Alzheimer’s disease pathology on cognition in the mutation carrier group of the Dominantly Inherited Alzheimer Network (DIAN) sample, we used linear mixed effects models, where we tested the interaction between gLFC-connectivity and estimated years from symptom onset (EYO) on cognitive measures

  • We found a significant interaction of gLFC-connectivity  EYO on both MMSE [b/standard error (SE) = 0.269/0.099, P = 0.008; Fig. 2A] and logical memory delayed free recall (b/SE = 0.275/ 0.106, P = 0.012; Fig. 2B)

Read more

Summary

Introduction

Biomarker studies in Alzheimer’s disease have revealed a temporal sequence of the development of brain pathologies and cognitive decline. Even in autosomal dominantly inherited Alzheimer’s disease (ADAD), where the course of Alzheimer’s disease development is strongly determined by mutations in genes encoding presinilin-1 (PSEN1), presenilin-2 (PSEN2) or amyloid precursor protein (APP), the cognitive status remains relatively stable in some patients despite advanced levels of amyloid-b and tau pathology (Lim et al, 2016). Neuroimaging studies on structural brain differences showed a larger premorbid brain volume to be an additional protective factor in Alzheimer’s disease (Perneczky et al, 2010; Meng and D’Arcy, 2012; Sumowski et al, 2014). The overall aim of the current study was to test particular functional brain features that support higher resilience of cognitive performance during the course of Alzheimer’s disease

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call